Get the latest Science News and Discoveries

Oncotarget: CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Immunotherapy

Immunotherapy

Related news:

New immunotherapy 'highly effective' against hepatitis B

New immunotherapy 'highly effective' against hepatitis B

New Immunotherapy “Highly Effective” Against Hepatitis B Virus

« Oncotarget: Phase 1 study of Z-Endoxifen in patients with solid tumors

Stair climbing offers significant cardiovascular and muscular benefits for heart patients »